Trichomonas vaginalis nucleic acid IVD, control - UK MHRA Medical Device Registration

Trichomonas vaginalis nucleic acid IVD, control is a medical device registered with the UK's Medicines and Healthcare products Regulatory Agency (MHRA) under Device ID 119254. The device is manufactured by Vircell, S.L. from Spain, classified as In Vitro Diagnostic Device. The authorized representative in the UK is Launch Diagnostics Limited.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, device classification, authorized representative details, and related products. Pure Global AI offers free access to 150,962+ UK MHRA medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

MHRA Registered

In Vitro Diagnostic Device

🇬🇧

Trichomonas vaginalis nucleic acid IVD, control

MHRA Device ID: 119254•Ref: 119254

Device Type

In Vitro Diagnostic Device

Devices

Trichomonas vaginalis nucleic acid IVD, control

Type

IVD General

Date Registered

Aug 23, 2024

Last Updated

Apr 5, 2024

Manufacturer Information

Name

Vircell, S.L.

Address

Parque Tecnológico de la Salud Avicena 8

Granada, Spain

Created Date

Jul 9, 2021

Authorized Representative

Name

Launch Diagnostics Limited

Relationship Type

UK Responsible Person

Address

Unit 20 Ash Way Thorp Arch Estate

Wetherby, England, United Kingdom

Postcode: LS23 7FA

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Other Products from Vircell, S.L. (10)

Other Products from Same Authorized Representative (10)

Trichomonas vaginalis nucleic acid IVD, control - UK MHRA Medical Device Registration

Device Type

Devices

Type

Date Registered

Last Updated

Name

Address

Created Date

Name

Relationship Type

Address

DJ Fang

Alpha-fetoprotein (AFP) IVD, kit, fluorescent immunoassay

Cyclic citrullinated peptide antibody (anti-CCP) IVD, kit, fluorescent immunoassay

Streptococcus pneumoniae antigen IVD, kit, rapid ICT, clinical

Allergen-specific/total immunoglobulin E (IgE) antibody IVD, kit, fluorescent immunoassay

C-reactive protein (CRP) IVD, kit, fluorescent immunoassay

Cryptosporidium species antigen IVD, kit, rapid ICT, clinical

Respiratory syncytial virus (RSV) antigen IVD, kit, rapid ICT, clinical

SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing

Trichomonas vaginalis antigen IVD, kit, rapid ICT, clinical

D-dimer IVD, kit, fluorescent immunoassay

Strongyloides stercoralis immunoglobulin G (IgG) antibody IVD, kit, enzyme immunoassay (EIA)

Herpes simplex virus 2 (HSV2) nucleic acid IVD, control

Tick-borne encephalitis (TBE) virus immunoglobulin G (IgG) antibody IVD, kit, chemiluminescent immunoassay

Human parainfluenza virus 4A nucleic acid IVD, control

Trichomonas vaginalis nucleic acid IVD, control

Multiple-type tropical pathogen nucleic acid IVD, kit, nucleic acid technique (NAT)

Multiple Mycoplasma species nucleic acid IVD, control

Varicella-zoster virus (VZV) nucleic acid IVD, control

Measles virus immunoglobulin M (IgM) antibody IVD, kit, chemiluminescent immunoassay

Hepatitis E virus immunoglobulin M (IgM) antibody IVD, kit, chemiluminescent immunoassay

Epstein-Barr virus (EBV) nucleic acid IVD, kit, nucleic acid technique (NAT)

Helicobacter pylori nucleic acid IVD, kit, nucleic acid technique (NAT)

Streptococcus pneumoniae nucleic acid IVD, kit, nucleic acid technique (NAT)

Coagulation factor II (prothrombin) mutation IVD, kit, nucleic acid technique (NAT)

Strongyloides stercoralis immunoglobulin G (IgG) antibody IVD, kit, enzyme immunoassay (EIA)

Cryptosporidium species antigen IVD, kit, enzyme immunoassay (EIA)

Multiple faecal parasite antigen IVD, kit, rapid ICT, clinical

Beta-haemolytic Group B Streptococcus nucleic acid IVD, kit, nucleic acid technique (NAT)

Clostridium difficile nucleic acid IVD, kit, nucleic acid technique (NAT)

Hepatitis B virus genotyping IVD, kit, nucleic acid technique (NAT)